Clinical Trials

Are you a woman 18 years old or older who has been diagnosed with LAM? This study is examining whether long-term treatment with medicine called sirolimus can stop lung damage in women who have LAM. This study takes place at multiple locations in the United States.

Do you or your child have primary ciliary dyskinesia (PCD)? This study aims to find out whether mild, moderate, or serious types of PCD are caused by different gene mutations. Researchers will test how well people who have various mutations, or gene changes, that cause PCD can clear mucus from their airways. Results from this study will help improve the diagnosis and treatment of PCD. This study takes place in Chapel Hill, North Carolina.

Do you or your child have PCD and want to help researchers better understand how cilia are formed? This study aims to identify the genes that control how cilia are formed. Cilia are hairlike structures that line the airways and protects the normal lung. The study will also identify how mutations to these genes can cause PCD. This study takes place in Chapel Hill, North Carolina.

Do you or your child have primary ciliary dyskinesia (PCD) or primary immune deficiency (PID)? This study aims to identify genes that cause these two conditions, which can have similar symptoms. The results from this study will help researchers find new ways to treat breathing and hearing problems caused by these two conditions in a cross-sectional cohort of patients with PCD and PID. Participants in this study must be 5 to 45 years old. This study is taking place at multiple locations in the United States and in Canada.

Do you or your child have symptoms of a serious lung disease but no diagnosis? This study aims to develop new ways to diagnose primary ciliary dyskinesia (PCD) and primary immune deficiency (PID), two conditions that can have similar symptoms. Researchers will combine information from genetic testing, lung imaging, and lung function tests to diagnose ant tell the difference between these two conditions. Participants in this study must be 5 to 45 years old. This study is taking place at multiple locations in the United States and in Canada.

Do you have pulmonary hypertension or scleroderma? This study aims to understand how scleroderma, a skin condition, can raise the risk of pulmonary hypertension and heart failure. The study will also test whether treatments for pulmonary hypertension in people who do not have scleroderma are effective in people who have both pulmonary hypertension and scleroderma. To participate in this study, you must be at least 18 years old and must have either pulmonary hypertension or scleroderma. This study is located in Maryland.

Are you a shift worker who regularly gets 7 to 9 hours of sleep each day? This study is looking at whether shift work negatively affects overall bone health. The study will test whether resuming and maintaining a daily schedule that aligns with the environment, after a period of night shift work, can help reverse bone problems. To participate in this study, you must be 20 to 40 years old. This study takes place in Aurora, Colorado.

Are you an adult with obstructive sleep apnea? This study is examining how using continuous positive airway pressure (CPAP) to treat sleep apnea affects a person’s blood oxygen levels, heart rate, and quality of sleep. To participate in this study, you must be between 20 and 80 years old with moderate to severe obstructive sleep apnea. This study takes place in Boston, Massachusetts.

Are you an adult with sleep apnea, overweight, or obesity, or do you just want to help research? This study is looking at how sleep apnea changes fat tissue in the body. The researchers will examine whether these changes in fat tissue may raise the risk of heart and blood vessel diseases. To participate in this study, you must be between 18 and 60 years old with obstructive sleep apnea and healthy without any chronic diseases. This study takes place in Rochester, Minnesota.

Is your child an individual with Down syndrome and obstructive sleep apnea? This study is examining whether a combination medication therapy that includes atomoxetine and oxybutynin can help treat obstructive sleep apnea in children with Down syndrome. Participants in this study must be between 6 and 17 years old. This study takes place in Tucson, Arizona.